NFKB1 and inflammatory bowel disease: Borniquel and colleagues have recently obtained results in a murine model of inflammatory bowel disease that are similar to ours in ALI [23], finding that OA-NO2 decreased disease severity and the increase in NF-κB expression while increasing expression of PPAR-γ.